文献速递临床试验与 GCP流行病学与生物统计

VIA Family 2.0研究:针对精神疾病患者子女的家庭干预随机临床试验方案

The VIA Family 2.0 study: a randomized clinical trial evaluating a family-based intervention for children born to parents with mental illnesses-study protocol.
PubMed 文献 · Trials · 2026-05-27

本研究为随机对照试验方案,纳入304名3-17岁和128名0-2岁儿童,其父母在过去三年内接受过精神科诊断与治疗。家庭基线评估后随机分入常规治疗组或VIA Family 2.0干预组,干预组由跨部门多学科团队提供个案管理支持,为期24个月。主要结局包括婴幼儿认知语言运动发育、儿童福祉行为社交发展、父母感知压力和家庭功能。

要点

  • 父母精神疾病子女面临心理健康问题与发育迟缓风险增高。
  • 干预组接受市政、儿童青少年精神科和成人精神科多学科团队支持。
  • 主要结局涵盖婴幼儿发育、儿童行为社交、父母压力与家庭功能。

核心结论

  • 该研究将评估跨部门多学科预防性干预相比常规治疗对父母近期患精神疾病家庭的疗效。

研究设计与样本

  • 随机对照试验纳入304名3-17岁儿童和128名0-2岁儿童,其父母有精神科诊断且过去三年内接受治疗。
  • 家庭基线评估后随机分入常规治疗组或VIA Family 2.0干预组,研究期24个月,基线及24个月后评估。

关键数值与推荐

  • 0-2岁婴幼儿主要结局为认知、语言和运动发育,采用Bayley-4评估。
  • 3-17岁儿童主要结局为福祉及行为社交发展,采用SDQ评估。
  • 父母主要结局为感知压力,采用父母压力量表(PSS)评估。
  • 家庭主要结局为家庭功能,采用家庭评估设备(FAD)评估。

临床怎么用

  • 干预组由市政服务、儿童青少年精神科和成人精神科专家组成的多学科团队负责,个案管理者协调支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Children of parents with mental illness face significant increased risks of developing mental health problems and experiencing developmental delays or other negative life outcomes due to genetic and environmental factors. Parental symptoms often disrupt caregiving, leading to family stress, inadequate routines, and insufficient stimulation and support in the home. Research, including findings from the Danish High Risk and Resilience Study, the VIA cohort, has shown substantial developmental, social, and cognitive challenges in these children. This study aims to evaluate the efficacy of a team-based, multidisciplinary preventive intervention compared with standard treatment for families with recent parental mental illness via a series of predefined outcome measures. METHODS/DESIGN: This randomized controlled trial, VIA Family 2.0, includes 304 children aged 3-17 years and 128 children aged 0-2 years with a parent with a psychiatric diagnosis and having received treatment within the past three years. The families will be assessed at baseline and thereafter randomized to either treatment as usual or VIA Family 2.0 intervention. The intervention group will be assigned to a multidisciplinary team with expertise from municipal services, child and adolescent psychiatry, and adult psychiatry. A case manager coordinates all the elements and supports the family with their challenges, on the basis of their own motivation. The study period is 24 months, and all participants will be assessed at baseline and after 24 months. The primary outcomes are cognitive, language and motor development for infants and toddlers aged 0-2 years (Bayley-4, Bayley Scales of Infant and Toddler Development), well-being and behavioral and social development for children aged 3-17 years (the Strengths and Difficulties Questionnaire (SDQ)), perceived parental stress for parents (Parental Stress Scale, PSS), and family functioning for the family (Family Assessment Device, FAD). DISCUSSION: This study examines the impact of a cross-sectoral intervention that integrates expertise across sectors. This study contributes critical knowledge about whether improving family resilience, supporting children's development, and reducing risk loads through holistic family support is possible. This research highlights the potential of preventive public health initiatives to promote well-being and reduce long-term adverse outcomes in a high-risk group of children and adolescents. TRIAL REGISTRATION: The study is registered at ClinicalTrials.Gov (NCT06312410) on March 15, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Heuckendorff S, Ranning A, Ingversen S, et al. The VIA Family 2.0 study: a randomized clinical trial evaluating a family-based intervention for children born to parents with mental illnesses-study protocol. Trials. 2026. PMID: 42192567. doi:10.1186/s13063-026-09792-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。